New Damage Control Resuscitation CPG Now Available
The JTS has published the updated Damage Control Resuscitation (DCR) Clinical Practice Guideline (CPG) filled with life-saving recommendations based on the latest research and best practices built on lessons learned on the frontlines and in medical treatment facilities. Below is a summary of changes found in the DCR CPG.
- Greater emphasis on the use of Low Titer O Whole Blood
- Updated risk factors for massive transfusion
- Earlier use of calcium use recommended for hemorrhagic shock (with transfusion) and for ongoing resuscitation
- Adjusted blood pressure goals for DCR for traumatic brain injury
- Resuscitative Endovascular Balloon Occlusion of the Aorta updated as a fielded option for the control of non-compressible torso hemorrhage by resuscitation teams.
- The discontinued use of hydroxyethyl starch (i.e. Hextend, Hespan) as a resuscitation fluid
- The discontinued use of recombinant human activated factor VII
back to top
Last Modified Date: 10/27/2020